John Nieland, PhD

John is 2N Pharma’s co-founder and CSO and brings broad management experience and in-depth research background. He was previously director of research at Medigene AG and is co-founder of the clinical-stage vaccine company 2A Pharma and two other biotech companies. In addition to his duties at 2N Pharma, John is also Associate Professor and Head of the Molecular Pharmacology Department at Aalborg University, Denmark.